Concept: Pharmaceutical industry and healthcare
Private hospital managers back legal regulation of healthcare advertising
Hospital managers' views on healthcare advertising regulation in Turkey
Industry payments were linked to more brand-name MS prescribing
How drug company payments to doctors influence multiple sclerosis prescription choices
Most favored nation drug pricing may lower industry research revenue
International drug pricing policy and pharmaceutical innovation capacity
Zuranolone was approved for postpartum depression, not major depressive disorder
How expedited drug approval processes may compromise regulatory safety standards
Principles-based authorship guidance is proposed for science
Establishing consistent authorship standards across institutions and journals
Private equity investment in emergency medicine raises ethical tensions
How private equity ownership reshapes ethics and operations in emergency departments
Review describes peer review denials, burdens, and navigation
How insurance review processes affect doctors, patients, and care quality
Rivaroxaban controversy linked to synthetic certainty
How a faulty blood-clotting monitor undermined evidence for a widely recommended stroke drug
Layered PPIE broadened involvement in the RETURN dental study
Expanding who has a voice in health research through multiple involvement approaches
Turkish drug recalls were driven by contamination, sterility, and safety issues
What causes Turkish health authorities to pull medications from shelves
